Ind-Swift Laboratories Allots 70 Lakh Convertible Warrants to Promoter Group
Ind-Swift Laboratories Ltd 路 Others (Uncategorized) 路 17 Sept 2026, 11:15 pm
Ind-Swift Laboratories Allots 70 Lakh Convertible Warrants to Promoter Group Ind-Swift Laboratories approved the allotment of 70,00,000 fully convertible warrants on a preferential basis to promoter group entity Essix Biosciences Limited on 17th Sep'26. The warrants were issued at Rs. 196 each (including a premium of Rs. 186). The company received the upfront 25% subscription price of Rs. 49 per warrant, aggregating to Rs. 34.30 crore. The preferential allotment follows shareholder approval obtained on 5th Aug'26 and in-principle approval from BSE and NSE on 16th Sep'26.
Original exchange filing (PDF)
More announcements from Ind-Swift Laboratories Ltd
- Please find enclosed transcript for earnings call held on November 04, 2026. 路 10 Nov 2026
- Audio recording of earning conference call held on 04.11.2026 on un-audited financial results for the quarter ended 30.09.2026. 路 05 Nov 2026
- Please find enclosed investor presentation on un-audited financial results for the quarter ended September 30, 2026 路 04 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of receipt of funds raised through preferential issue of 70,00,000 Fully Convertible Warrants 路 03 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 in respect of funds raised through Preferential Issue 2.6 Cr Fully Convertible Warrants 路 03 Nov 2026
- Please find enclosed Schedule of Analyst / Investor Meet which will be held on Wednesday, November 04, 2026, at 04.00 P.M. IST in respect of financial results of the Company for the quarter .... 路 04 Nov 2026
- Press Release in respect of Unaudited Financial Results (Standalone & Consolidated) for the second quarter and half year ended September 30, 2026 路 30 Oct 2026
- Please refer attached pdf 路 30 Oct 2026
